Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1960 1
1968 2
1969 5
1970 3
1975 1
1978 1
1979 1
1980 1
1981 2
1982 2
1983 2
1984 1
1986 2
1988 3
1989 2
1990 1
1991 1
1992 5
1994 2
1995 5
1996 5
1997 1
2000 3
2002 3
2003 2
2004 2
2005 1
2006 1
2007 6
2008 4
2009 7
2010 7
2011 4
2012 4
2013 4
2014 5
2015 6
2016 9
2017 7
2018 10
2019 6
2020 3
2021 8
2022 10
2023 11
2024 23
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group. Enden T, et al. Lancet. 2012 Jan 7;379(9810):31-8. doi: 10.1016/S0140-6736(11)61753-4. Epub 2011 Dec 13. Lancet. 2012. PMID: 22172244 Free article. Clinical Trial.
In Reply.
Schulz N. Schulz N. Dtsch Arztebl Int. 2024 Nov 1;121(22):756. doi: 10.3238/arztebl.m2024.0199. Dtsch Arztebl Int. 2024. PMID: 39841492 Free PMC article. No abstract available.
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study.
Kernder A, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, Klemm P, Krusche M, Meinecke A, Rech J, Schulz N, Petzinna SM, Pankow A, Schäfer VS, Pfeil A, Klapa S, Feist E, Vordenbäumen S. Kernder A, et al. Among authors: schulz n. Lancet Rheumatol. 2025 Jun;7(6):e415-e423. doi: 10.1016/S2665-9913(25)00023-2. Epub 2025 Mar 28. Lancet Rheumatol. 2025. PMID: 40164168 Free article.
[Lifestyle medication vitamin D. What evidence is available?].
Lange U, Schulz N, Klemm P. Lange U, et al. Among authors: schulz n. Z Rheumatol. 2023 Dec;82(10):877-881. doi: 10.1007/s00393-023-01392-9. Epub 2023 Jul 28. Z Rheumatol. 2023. PMID: 37505295 Free PMC article. Review. German.
[44-year-old patient with back pain].
Wendel M, Klemm P, Schulz N. Wendel M, et al. Among authors: schulz n. Dtsch Med Wochenschr. 2024 Jan;149(1-02):13-14. doi: 10.1055/a-2195-3738. Epub 2023 Dec 29. Dtsch Med Wochenschr. 2024. PMID: 38158201 German. No abstract available.
Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis.
Heck C, Zimmermann-Geller B, Haun S, Lötfering F, Welbrink P, Kürsammer D, Frommer KW, Arnold-Gräf M, Korb-Pap A, Knothe A, Schulz N, Simianer S, Tarner I, Hermann W, Biehl C, Günther S, Steinmeyer J, Lips KS, Rickert M, Rehart S, Müller-Ladner U, Neumann E. Heck C, et al. Among authors: schulz n. Ann Rheum Dis. 2025 Jun 20:S0003-4967(25)01026-X. doi: 10.1016/j.ard.2025.05.019. Online ahead of print. Ann Rheum Dis. 2025. PMID: 40541454 Free article.
191 results